Animal models of atherosclerosis and magnetic resonance imaging for monitoring plaque progression

Vascular ◽  
2014 ◽  
Vol 22 (3) ◽  
pp. 221-237 ◽  
Author(s):  
Antoine Millon ◽  
Emmanuelle Canet-Soulas ◽  
Loic Boussel ◽  
Zahi Fayad ◽  
Philippe Douek

Atherosclerosis, the main cause of heart attack and stroke, is the leading cause of death in most modern countries. Preventing clinical events depends on a better understanding of the mechanism of atherosclerotic plaque destabilization. Our knowledge on the characteristics of vulnerable plaques in humans has grown past decades. Histological studies have provided a precise definition of high-risk lesions and novel imaging methods for human atherosclerotic plaque characterization have made significant progress. However the pathological mechanisms leading from stable lesions to the formation of vulnerable plaques remain uncertain and the related clinical events are unpredictable. An animal model mimicking human plaque destablization is required as well as an in vivo imaging method to assess and monitor atherosclerosis progression. Magnetic resonance imaging (MRI) is increasingly used for in vivo assessment of atherosclerotic plaques in the human carotids. MRI provides well-characterized morphological and functional features of human atherosclerotic plaque which can be also assessed in animal models. This review summarizes the most common species used as animal models for experimental atherosclerosis, the techniques to induce atherosclerosis and to obtain vulnerable plaques, together with the role of MRI for monitoring atherosclerotic plaques in animals.

Author(s):  
Ruiqing Ni

Amyloid-beta plays an important role in the pathogenesis of Alzheimer’s disease. Aberrant amyloid-beta and tau accumulation induce neuroinflammation, cerebrovascular alterations, synaptic deficits, functional deficits, and neurodegeneration, leading to cognitive impairment. Animal models recapitulating the amyloid-beta pathology such as transgenic, knock-in mouse and rat models have facilitated the understanding of disease mechanisms and development of therapeutics targeting at amyloid-beta. There is a rapid advance in high-field MR in small animals. Versatile high-field magnetic resonance imaging (MRI) sequences such as diffusion tensor imaging, arterial spin labelling, resting-state functional MRI, anatomical MRI, MR spectroscopy as well as contrast agents have been developed for the applications in animal models. These tools have enabled high-resolution in vivo structural, functional, and molecular readouts with a whole brain field-of-view. MRI have been utilized to visualize non-invasively the amyloid-beta deposits, synaptic deficits, regional brain atrophy, impairment in white matter integrity, functional connectivity, cerebrovascular and glymphatic system in animal models of amyloidosis. Many of the readouts are translational in clinical MRI in the brain of patients with Alzheimer’s disease. In this review, we summarize the recent advance of using MRI for visualizing the pathophysiology in amyloidosis animal model. We discuss the outstanding challenges in brain imaging using MRI in small animal and propose future outlook in visualizing amyloid-beta-related alterations in brain of animal models.


PLoS ONE ◽  
2012 ◽  
Vol 7 (9) ◽  
pp. e45008 ◽  
Author(s):  
Dominik von Elverfeldt ◽  
Constantin von zur Muhlen ◽  
Kristina Wiens ◽  
Irene Neudorfer ◽  
Andreas Zirlik ◽  
...  

Circulation ◽  
2004 ◽  
Vol 109 (23) ◽  
pp. 2890-2896 ◽  
Author(s):  
Marc Sirol ◽  
Vitalii V. Itskovich ◽  
Venkatesh Mani ◽  
Juan Gilberto S. Aguinaldo ◽  
John T. Fallon ◽  
...  

2004 ◽  
Vol 20 (1) ◽  
pp. 105-110 ◽  
Author(s):  
Vincent C. Cappendijk ◽  
Kitty B.J.M. Cleutjens ◽  
Sylvia Heeneman ◽  
Geert Willem H. Schurink ◽  
Rob J.Th.J. Welten ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document